ArticleCancer discovery2026
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer.
Franziska Siegel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleCancer discovery2026
Franziska Siegel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.